December 8, 2017
October 24, 2017
[vc_row][vc_column][vc_column_text] Philadelphia-based Spark Therapeutics recently received unanimous backing from an FDA advisory panel for Luxturna™, a one-shot gene therapy treatment for biallelic RPE65-mediated inherited retinal dystrophy […]
October 16, 2017
[vc_row][vc_column][vc_column_text] German pharmaceutical company Evotec has expanded its partnership with Scottish artificial intelligence drug design pioneers Exscientia, investing a further €15m in exchange for a minority […]
October 5, 2017
[vc_row][vc_column][vc_column_text] The global therapeutic IPO market has failed to maintain the upward momentum established throughout a busy Q2 2017, with just over $1B raised by 13 […]
September 26, 2017
August 22, 2017
[vc_row][vc_column][vc_column_text]Scientists at e-Genesis, a Massachusetts-based biotech firm, recently announced that they have successfully utilised CRISPR gene-editing technology to inactivate Porcine Endogenous Retroviruses (PERVs) in a line […]
July 14, 2017
[vc_row][vc_column][vc_column_text] England’s Chief Medical Officer, Dame Sally Davies, recently called for making genomic testing as common as blood tests in order to usher in the era […]
July 6, 2017
[vc_row][vc_column][vc_column_text] After a well-documented lull in 2016 and a sluggish start to 2017, the global therapeutic IPO market has started to bounce back in Q2, […]
May 23, 2017
[vc_row][vc_column][vc_column_text] Dutch Contract Development & Manufacturing Organisation Patheon has been acquired by Thermo Fisher Scientific in a $7.2B deal. The acquisition, which includes the assumption of […]